IRTC Stock Analysis: Buy, Sell, or Hold?
IRTC - iRhythm Technologies, Inc
$110.12
5.43 (5.19%)
▲
5d:
-3.2%
30d:
-6.58%
90d:
-6.79%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Get Alerted When IRTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IRTC shows positive signals but monitor for confirmation. Market pricing in 7.3% decline. Moderate conviction.
💡 BUY OPPORTUNITY: IRTC shows positive signals but monitor for confirmation. Market pricing in 7.3% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$51.18
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$31.78
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IRTC is currently trading at $110.12, which is considered fair relative to its 30-day fair value range of $106.48 to $115.23. From a valuation perspective, the stock is trading at a discount (Forward PE: 104.8) compared to its historical average (131.5). Remarkably, the market is currently pricing in an annual earnings decline of 7.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IRTC is in a strong downtrend. Immediate support is located at $100.85, while resistance sits at $118.08. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: IRTC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $178.93 (+62.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IRTC is in a strong downtrend. Immediate support is located at $100.85, while resistance sits at $118.08. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: IRTC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $178.93 (+62.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$106.48 -
$115.23
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.5%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.2%)
- BULLISH: Trading 62.5% below Wall St target ($178.93)
Trading Range Analysis
30-Day Trading Range
$106.48 -
$115.23
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$8.55
(7.8%)
Support & Resistance Levels
Support Level
$100.85
Resistance Level
$118.08
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
104.75
Wall Street Target
$178.93
(+62.5%)
Revenue Growth (YoY)
25.7%
Profit Margin
-3.5%
Valuation Discount vs History
-7.3% cheaper
PE vs Historical
104.8 vs 131.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.3%
(market-implied from PE analysis)
1-Year Target
$102.08
(-7%)
2-Year Target
$94.63
(-14%)
3-Year Target
$87.72
(-20%)
3-Yr Target (if PE normalizes)
(PE: 105→132)
$110.13
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 104.7, Growth: 800.1%)
$371.66
(+238%)
Base:
(SPY PE: 21.8, Growth: 800.1%)
$77.28
(-30%)
Bear:
(PE: 18.5, Growth: 800.1%)
$65.69
(-40%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 104.7 to 131.5
Stabilization Target:
$138.25
(+25.5%)
PE Expansion Potential:
+25.5%
Share & Embed Analysis
Last updated: June 24, 2026 4:54 AM ET
Data refreshes hourly during market hours. Next update: 5:54 AM
Data refreshes hourly during market hours. Next update: 5:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
17
Sells
Net
INSIDERS SELLING
Recent Transactions
Marc Wade Rosenbaum
SELL
816 shares
2026-03-02
Chad Patterson
SELL
4444 shares
2026-03-02
Sumi Shrishrimal
SELL
2830 shares
2026-03-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
Advanced IRTC Option Strategies
Professional options setups generated by AI based on today's IRTC price and gamma walls.
